跳至主要内容
临床试验/IRCT138807262602N1
IRCT138807262602N1已完成3 期

Effect of hazelnut consumption on lipid profile, Apo B, Apo A-I, hs-CRP and Paraoxonase-1 in patients with type 2 diabetes.

Iran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 70 years(—)
性别
All

入选标准

  • Being volunteer or Wishing to attend, 35-70 y old, diagnosed with type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl), BMI = 35 kg/m2, TG < 400 mg/dl, HbA1C < 9%, LDL = 200 mg/dl, Blood pressure =160/90 mmHg
  • Exclusion criteria: Allergy to nuts, Taking insulin, Smoking cigarette, drinking alcohol or drug abuse, Following vegetarian or weight-reducing diet 2 months before the study, Diabetic nephropathy or retinopathy, History of stroke or heart attack, Thyroid disease, Eating nuts > 2 times/wk at least 2 months before the study, Changing medication dosage or physical activity level 2 mo before or during the study

排除标准

  • 未提供

研究者

相似试验